 | • レポートコード：MRC2Q12-16725 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、抗精神病薬のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 抗精神病薬のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 抗精神病薬の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 抗精神病薬のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの抗精神病薬の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の抗精神病薬の売上および2028年までの予測に焦点を当てています。 抗精神病薬のグローバル主要企業には、Johnson and Johnson、Eli Lilly、Bristol-Myers Squibb、AstraZeneca、Novartis、Allergan、Pfizer、GlaxoSmithKline、Otsuka Pharma、Sumitomo Dainippon、Alkermes、Vanda Pharmaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 抗精神病薬市場は、タイプとアプリケーションによって区分されます。世界の抗精神病薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 経口抗精神病薬、注射抗精神病薬 【アプリケーション別セグメント】 病院薬局、クリニック薬局、オンライン薬局 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 抗精神病薬製品概要 - タイプ別市場（経口抗精神病薬、注射抗精神病薬） - アプリケーション別市場（病院薬局、クリニック薬局、オンライン薬局） - 調査の目的 ・エグゼクティブサマリー - 世界の抗精神病薬販売量予測2017-2028 - 世界の抗精神病薬売上予測2017-2028 - 抗精神病薬の地域別販売量 - 抗精神病薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別抗精神病薬販売量 - 主要メーカー別抗精神病薬売上 - 主要メーカー別抗精神病薬価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（経口抗精神病薬、注射抗精神病薬） - 抗精神病薬のタイプ別販売量 - 抗精神病薬のタイプ別売上 - 抗精神病薬のタイプ別価格 ・アプリケーション別市場規模（病院薬局、クリニック薬局、オンライン薬局） - 抗精神病薬のアプリケーション別販売量 - 抗精神病薬のアプリケーション別売上 - 抗精神病薬のアプリケーション別価格 ・北米市場 - 北米の抗精神病薬市場規模（タイプ別、アプリケーション別） - 主要国別の抗精神病薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの抗精神病薬市場規模（タイプ別、アプリケーション別） - 主要国別の抗精神病薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の抗精神病薬市場規模（タイプ別、アプリケーション別） - 主要国別の抗精神病薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の抗精神病薬市場規模（タイプ別、アプリケーション別） - 主要国別の抗精神病薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの抗精神病薬市場規模（タイプ別、アプリケーション別） - 主要国別の抗精神病薬市場規模（トルコ、サウジアラビア） ・企業情報 Johnson and Johnson、Eli Lilly、Bristol-Myers Squibb、AstraZeneca、Novartis、Allergan、Pfizer、GlaxoSmithKline、Otsuka Pharma、Sumitomo Dainippon、Alkermes、Vanda Pharma ・産業チェーン及び販売チャネル分析 - 抗精神病薬の産業チェーン分析 - 抗精神病薬の原材料 - 抗精神病薬の生産プロセス - 抗精神病薬の販売及びマーケティング - 抗精神病薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 抗精神病薬の産業動向 - 抗精神病薬のマーケットドライバー - 抗精神病薬の課題 - 抗精神病薬の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Antipsychotic Medicine estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Antipsychotic Medicine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Antipsychotic Medicine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Antipsychotic Medicine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Antipsychotic Medicine include Johnson and Johnson, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Novartis, Allergan, Pfizer, GlaxoSmithKline and Otsuka Pharma, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Antipsychotic Medicine companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Antipsychotic Medicine market. Further, it explains the major drivers and regional dynamics of the global Antipsychotic Medicine market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Johnson and Johnson
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Novartis
Allergan
Pfizer
GlaxoSmithKline
Otsuka Pharma
Sumitomo Dainippon
Alkermes
Vanda Pharma
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Antipsychotic Medicine Segment by Type
Oral Antipsychotics
Injectable Antipsychotics
Antipsychotic Medicine Segment by Application
Hospital Pharmacy
Clinic Pharmacy
Online Pharmacy
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Antipsychotic Medicine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Antipsychotic Medicine market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Antipsychotic Medicine, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Antipsychotic Medicine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Antipsychotic Medicine revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Antipsychotic Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Antipsychotic Medicine revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Johnson and Johnson, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Novartis, Allergan, Pfizer, GlaxoSmithKline and Otsuka Pharma, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Antipsychotic Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antipsychotic Medicine companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antipsychotic Medicine revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antipsychotic Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral Antipsychotics
1.2.3 Injectable Antipsychotics
1.3 Market by Application
1.3.1 Global Antipsychotic Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Clinic Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Antipsychotic Medicine Market Perspective (2017-2028)
2.2 Antipsychotic Medicine Growth Trends by Region
2.2.1 Antipsychotic Medicine Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Antipsychotic Medicine Historic Market Size by Region (2017-2022)
2.2.3 Antipsychotic Medicine Forecasted Market Size by Region (2023-2028)
2.3 Antipsychotic Medicine Market Dynamics
2.3.1 Antipsychotic Medicine Industry Trends
2.3.2 Antipsychotic Medicine Market Drivers
2.3.3 Antipsychotic Medicine Market Challenges
2.3.4 Antipsychotic Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antipsychotic Medicine Players by Revenue
3.1.1 Global Top Antipsychotic Medicine Players by Revenue (2017-2022)
3.1.2 Global Antipsychotic Medicine Revenue Market Share by Players (2017-2022)
3.2 Global Antipsychotic Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antipsychotic Medicine Revenue
3.4 Global Antipsychotic Medicine Market Concentration Ratio
3.4.1 Global Antipsychotic Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antipsychotic Medicine Revenue in 2021
3.5 Antipsychotic Medicine Key Players Head office and Area Served
3.6 Key Players Antipsychotic Medicine Product Solution and Service
3.7 Date of Enter into Antipsychotic Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antipsychotic Medicine Breakdown Data by Type
4.1 Global Antipsychotic Medicine Historic Market Size by Type (2017-2022)
4.2 Global Antipsychotic Medicine Forecasted Market Size by Type (2023-2028)
5 Antipsychotic Medicine Breakdown Data by Application
5.1 Global Antipsychotic Medicine Historic Market Size by Application (2017-2022)
5.2 Global Antipsychotic Medicine Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Antipsychotic Medicine Market Size (2017-2028)
6.2 North America Antipsychotic Medicine Market Size by Type
6.2.1 North America Antipsychotic Medicine Market Size by Type (2017-2022)
6.2.2 North America Antipsychotic Medicine Market Size by Type (2023-2028)
6.2.3 North America Antipsychotic Medicine Market Share by Type (2017-2028)
6.3 North America Antipsychotic Medicine Market Size by Application
6.3.1 North America Antipsychotic Medicine Market Size by Application (2017-2022)
6.3.2 North America Antipsychotic Medicine Market Size by Application (2023-2028)
6.3.3 North America Antipsychotic Medicine Market Share by Application (2017-2028)
6.4 North America Antipsychotic Medicine Market Size by Country
6.4.1 North America Antipsychotic Medicine Market Size by Country (2017-2022)
6.4.2 North America Antipsychotic Medicine Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Antipsychotic Medicine Market Size (2017-2028)
7.2 Europe Antipsychotic Medicine Market Size by Type
7.2.1 Europe Antipsychotic Medicine Market Size by Type (2017-2022)
7.2.2 Europe Antipsychotic Medicine Market Size by Type (2023-2028)
7.2.3 Europe Antipsychotic Medicine Market Share by Type (2017-2028)
7.3 Europe Antipsychotic Medicine Market Size by Application
7.3.1 Europe Antipsychotic Medicine Market Size by Application (2017-2022)
7.3.2 Europe Antipsychotic Medicine Market Size by Application (2023-2028)
7.3.3 Europe Antipsychotic Medicine Market Share by Application (2017-2028)
7.4 Europe Antipsychotic Medicine Market Size by Country
7.4.1 Europe Antipsychotic Medicine Market Size by Country (2017-2022)
7.4.2 Europe Antipsychotic Medicine Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antipsychotic Medicine Market Size (2017-2028)
8.2 Asia-Pacific Antipsychotic Medicine Market Size by Type
8.2.1 Asia-Pacific Antipsychotic Medicine Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Antipsychotic Medicine Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Antipsychotic Medicine Market Share by Type (2017-2028)
8.3 Asia-Pacific Antipsychotic Medicine Market Size by Application
8.3.1 Asia-Pacific Antipsychotic Medicine Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Antipsychotic Medicine Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Antipsychotic Medicine Market Share by Application (2017-2028)
8.4 Asia-Pacific Antipsychotic Medicine Market Size by Region
8.4.1 Asia-Pacific Antipsychotic Medicine Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Antipsychotic Medicine Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Antipsychotic Medicine Market Size (2017-2028)
9.2 Latin America Antipsychotic Medicine Market Size by Type
9.2.1 Latin America Antipsychotic Medicine Market Size by Type (2017-2022)
9.2.2 Latin America Antipsychotic Medicine Market Size by Type (2023-2028)
9.2.3 Latin America Antipsychotic Medicine Market Share by Type (2017-2028)
9.3 Latin America Antipsychotic Medicine Market Size by Application
9.3.1 Latin America Antipsychotic Medicine Market Size by Application (2017-2022)
9.3.2 Latin America Antipsychotic Medicine Market Size by Application (2023-2028)
9.3.3 Latin America Antipsychotic Medicine Market Share by Application (2017-2028)
9.4 Latin America Antipsychotic Medicine Market Size by Country
9.4.1 Latin America Antipsychotic Medicine Market Size by Country (2017-2022)
9.4.2 Latin America Antipsychotic Medicine Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antipsychotic Medicine Market Size (2017-2028)
10.2 Middle East & Africa Antipsychotic Medicine Market Size by Type
10.2.1 Middle East & Africa Antipsychotic Medicine Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Antipsychotic Medicine Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Antipsychotic Medicine Market Share by Type (2017-2028)
10.3 Middle East & Africa Antipsychotic Medicine Market Size by Application
10.3.1 Middle East & Africa Antipsychotic Medicine Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Antipsychotic Medicine Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Antipsychotic Medicine Market Share by Application (2017-2028)
10.4 Middle East & Africa Antipsychotic Medicine Market Size by Country
10.4.1 Middle East & Africa Antipsychotic Medicine Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Antipsychotic Medicine Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Details
11.1.2 Johnson and Johnson Business Overview
11.1.3 Johnson and Johnson Antipsychotic Medicine Introduction
11.1.4 Johnson and Johnson Revenue in Antipsychotic Medicine Business (2017-2022)
11.1.5 Johnson and Johnson Recent Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Antipsychotic Medicine Introduction
11.2.4 Eli Lilly Revenue in Antipsychotic Medicine Business (2017-2022)
11.2.5 Eli Lilly Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Antipsychotic Medicine Introduction
11.3.4 Bristol-Myers Squibb Revenue in Antipsychotic Medicine Business (2017-2022)
11.3.5 Bristol-Myers Squibb Recent Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Antipsychotic Medicine Introduction
11.4.4 AstraZeneca Revenue in Antipsychotic Medicine Business (2017-2022)
11.4.5 AstraZeneca Recent Developments
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Antipsychotic Medicine Introduction
11.5.4 Novartis Revenue in Antipsychotic Medicine Business (2017-2022)
11.5.5 Novartis Recent Developments
11.6 Allergan
11.6.1 Allergan Company Details
11.6.2 Allergan Business Overview
11.6.3 Allergan Antipsychotic Medicine Introduction
11.6.4 Allergan Revenue in Antipsychotic Medicine Business (2017-2022)
11.6.5 Allergan Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Antipsychotic Medicine Introduction
11.7.4 Pfizer Revenue in Antipsychotic Medicine Business (2017-2022)
11.7.5 Pfizer Recent Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Antipsychotic Medicine Introduction
11.8.4 GlaxoSmithKline Revenue in Antipsychotic Medicine Business (2017-2022)
11.8.5 GlaxoSmithKline Recent Developments
11.9 Otsuka Pharma
11.9.1 Otsuka Pharma Company Details
11.9.2 Otsuka Pharma Business Overview
11.9.3 Otsuka Pharma Antipsychotic Medicine Introduction
11.9.4 Otsuka Pharma Revenue in Antipsychotic Medicine Business (2017-2022)
11.9.5 Otsuka Pharma Recent Developments
11.10 Sumitomo Dainippon
11.10.1 Sumitomo Dainippon Company Details
11.10.2 Sumitomo Dainippon Business Overview
11.10.3 Sumitomo Dainippon Antipsychotic Medicine Introduction
11.10.4 Sumitomo Dainippon Revenue in Antipsychotic Medicine Business (2017-2022)
11.10.5 Sumitomo Dainippon Recent Developments
11.11 Alkermes
11.11.1 Alkermes Company Details
11.11.2 Alkermes Business Overview
11.11.3 Alkermes Antipsychotic Medicine Introduction
11.11.4 Alkermes Revenue in Antipsychotic Medicine Business (2017-2022)
11.11.5 Alkermes Recent Developments
11.12 Vanda Pharma
11.12.1 Vanda Pharma Company Details
11.12.2 Vanda Pharma Business Overview
11.12.3 Vanda Pharma Antipsychotic Medicine Introduction
11.12.4 Vanda Pharma Revenue in Antipsychotic Medicine Business (2017-2022)
11.12.5 Vanda Pharma Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer